Parecoxib Sodium contains not less than 98.0% w/w and not more than 102.0% w/w of C19H17N2O4SNa (on anhydrous and solvent free basis)

帕瑞昔布鈉
Parecoxib Sodium

• 申請商: 台灣荃新股份有限公司
• 適應症: 使用於外科手術後疼痛之緩解
• 含量: 0